GLOBAL INDEMNITY ($GBLI) posted quarterly earnings results for Q4 2025 on Tuesday, March 10th. The company reported earnings of $0.44 per share, missing estimates of $0.91 by $0.47. The company also reported revenue of $116,730,000, missing estimates of $119,497,080 by $-2,767,080.
You can see Quiver Quantitative's $GBLI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GLOBAL INDEMNITY Insider Trading Activity
GLOBAL INDEMNITY insiders have traded $GBLI stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GBLI stock by insiders over the last 6 months:
- JOSEPH W BROWN (Chief Executive Officer) purchased 5,000 shares for an estimated $129,900
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GLOBAL INDEMNITY Hedge Fund Activity
We have seen 10 institutional investors add shares of GLOBAL INDEMNITY stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CANNELL CAPITAL LLC removed 86,415 shares (-30.6%) from their portfolio in Q4 2025, for an estimated $2,452,457
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 23,300 shares (-2.4%) from their portfolio in Q4 2025, for an estimated $661,254
- BOSTON PARTNERS added 13,181 shares (+9.6%) to their portfolio in Q4 2025, for an estimated $374,076
- MARYLAND CAPITAL ADVISORS INC. added 11,629 shares (+inf%) to their portfolio in Q4 2025, for an estimated $330,031
- AMERIPRISE FINANCIAL INC added 5,457 shares (+1.8%) to their portfolio in Q4 2025, for an estimated $154,869
- MORGAN STANLEY added 2,844 shares (+218.1%) to their portfolio in Q4 2025, for an estimated $80,712
- UBS GROUP AG removed 2,573 shares (-96.0%) from their portfolio in Q4 2025, for an estimated $73,021
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
